US Stock Market Move | Regencell Bioscience Holdings Ltd. (RGC.US) surged over 26%, with a market value approaching 400 million US dollars.

On Friday, Regencell Bioscience Holdings Ltd. (RGC.US) surged over 26%, reaching $30.70 per share. As of the time of writing, the company's market value has reached $399 million. Regencell Bioscience Holdings Ltd. is a early-stage biotechnology company focused on the research and commercialization of traditional Chinese medicine for the treatment of neurological cognitive disorders and degenerative diseases, particularly ADHD and ASD.